We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Engineering of pulmonary surfactant corona on inhaled nanoparticles to operate in the lung system
Summary
Researchers reviewed how inhaled nanoparticles become coated with lung surfactant — the fluid lining the air sacs of the lungs — forming a protein-lipid shell that changes how the particles interact with cells and affects how toxic they are. Understanding this coating process is key to designing safer inhaled drug delivery systems and predicting how airborne nanoplastics and other nanoparticles behave once they reach deep lung tissue.
Exposure of inhaled nanoparticles (NPs) to the deep lung tissue results in the adsorption of pulmonary surfactant (PSf) on the surface of NPs and the formation of a biomolecular corona. The adsorption of the peculiar phospholipids (PLs) and surfactant proteins (SPs) provides NPs with a new bio-identity, which likely changes their corresponding interactions with cells and other bio-systems. Exploring the interaction of NPs with the PSf film at the alveolar air-fluid interface can provide valuable insights into the role of biofluids in the cellular uptake of NPs and their nanotoxic effects. Wrapping biomembranes around NPs and the formation of lipoprotein corona regulate viscoelastic changes, NP insertion into the membrane, and cellular uptake of NPs. In this review, a concise overview has been presented on the engineering of PSf on inhaled NPs to operate in lung environment. First, the physiological barriers in the pulmonary delivery of NPs and approaches to regulating their pulmonary fate are introduced and rationalized. Next, a short description is given on the different sources used for exploring the interfacial performance of inhaled NPs in vitro. A discussion is then presented on SP corona formation on the surface of inhaled NPs, coronal proteome/lipidome in respiratory tract lining fluid (RTLF), regulation of NP aggregation and surfactant flow characteristics, PSf corona and its functional role in the cellular uptake of NPs, followed by explanations on the clinical correlations of PSf corona formation/inhibition on the surface of NPs. Finally, the challenges and future perspectives of the field have been discussed. This review can be harnessed to exploit PSf for the development of safe and bio-inspired pulmonary drug delivery strategies.
Sign in to start a discussion.
More Papers Like This
Molecular modeling of nanoplastic transformations in alveolar fluid and impacts on the lung surfactant film
Researchers used molecular dynamics simulations to model how inhaled nanoplastics interact with lung surfactant fluid at the air-water interface in the lungs. They found that lung surfactant molecules spontaneously coat nanoplastics to form coronas, and that some plastic types can be dissolved by lung surfactant, potentially increasing the bioavailability of toxic additives. The study suggests that nanoplastics could disrupt normal lung surfactant function, raising concerns about respiratory health effects.
Lipid Corona Formation on Micro- and Nanoplastic Particles Modulates Uptake and Toxicity in A549 Cells
Researchers found that lipid corona formation on micro- and nanoplastic particles significantly modulates their cellular uptake and toxicity in human lung cells, suggesting that biological coatings alter how plastic particles interact with human tissues.
Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy
Researchers reviewed how engineering the protein corona — the layer of proteins that coats nanoparticles in biological fluids — through modifications like PEGylation and protein pre-coating can improve nanoparticle targeting for cancer drug delivery by controlling how immune cells recognize and clear the particles.
Interactions between inhalable aged microplastics and lung surfactant: Potential pulmonary health risks
Researchers examined how aged microplastics that have been weathered in the environment interact with lung surfactant, the thin liquid layer that lines the airways and aids breathing. They found that aged microplastics disrupted surfactant function more severely than pristine particles, potentially impairing the lungs' ability to expand and protect against inhaled pollutants. The study suggests that the weathering process makes airborne microplastics more hazardous to respiratory health over time.
Understanding interactions between oligomeric plastic and lung-sufactants underpinning inhalation risks of airborne plastics
Researchers investigated how oligomeric plastic particles interact with lung surfactant bilayers to understand inhalation risks, proposing that as plastics break down to oligomeric sizes through environmental degradation they may penetrate and disrupt the protective surfactant layer lining the lungs.